Kevetrin hydrochloride is primarily utilized in the field of oncology as an investigational drug for the treatment of various types of cancer. It functions by targeting and modulating the p53 pathway, which plays a crucial role in regulating cell cycle and apoptosis. This mechanism makes it particularly effective in inducing cancer cell death while sparing normal, healthy cells. Its application is currently being explored in clinical trials to assess its efficacy and safety in treating solid tumors and hematologic malignancies. Researchers are also studying its potential in combination therapies to enhance overall treatment outcomes for cancer patients.